275 related articles for article (PubMed ID: 26081252)
21. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
Benze G; Geyer A; Alt-Epping B; Nauck F
Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
[TBL] [Abstract][Full Text] [Related]
22. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
Nolte MJ; Berkery R; Pizzo B; Baltzer L; Grossano D; Lucarelli CD; Kris MG
J Clin Oncol; 1998 Feb; 16(2):771-8. PubMed ID: 9469369
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.
McKenzie E; Zaki P; Raman S; Olson R; McFarlane T; DeAngelis C; Chan S; Pidduck W; Razvi Y; Bushehri A; Chow E
Support Care Cancer; 2019 Mar; 27(3):783-791. PubMed ID: 30607675
[TBL] [Abstract][Full Text] [Related]
24. Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.
Affronti ML; Schneider SM; Herndon JE; Schlundt S; Friedman HS
Support Care Cancer; 2014 Jul; 22(7):1897-905. PubMed ID: 24570103
[TBL] [Abstract][Full Text] [Related]
25. Recent Advances in Antiemetics: New Formulations of 5-HT3 Receptor Antagonists in Adults.
Smith C; Smith M; Cunningham R; Davis S
Cancer Nurs; 2020; 43(4):E217-E228. PubMed ID: 30688665
[TBL] [Abstract][Full Text] [Related]
26. [The survey for anti-emetic guideline by using questioner].
Saeki T; Tamura K; Aiba K; Aogi K; Iino K; Imamura C; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Matsuura K; Wada M; Akechi T; Kakudo Y; Kim YI; Sasaki H; Shima Y; Takeda M; Nagasaki E; Nishidate T; Saito M; Ashikaga Y; Tanigawara Y; Hirata K; Ishioka C; Nishiyama M
Gan To Kagaku Ryoho; 2015 Mar; 42(3):305-11. PubMed ID: 25812498
[TBL] [Abstract][Full Text] [Related]
27. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
Jordan K; Sippel C; Schmoll HJ
Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
[TBL] [Abstract][Full Text] [Related]
28. [Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J; Szántó J
Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
[TBL] [Abstract][Full Text] [Related]
29. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.
Jordan K; Gralla R; Jahn F; Molassiotis A
Eur J Pharmacol; 2014 Jan; 722():197-202. PubMed ID: 24157984
[TBL] [Abstract][Full Text] [Related]
30. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
; Kris MG; Hesketh PJ; Somerfield MR; Feyer P; Clark-Snow R; Koeller JM; Morrow GR; Chinnery LW; Chesney MJ; Gralla RJ; Grunberg SM
J Clin Oncol; 2006 Jun; 24(18):2932-47. PubMed ID: 16717289
[TBL] [Abstract][Full Text] [Related]
31. Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice.
Molassiotis A; Brearley SG; Stamataki Z
Support Care Cancer; 2011 Jul; 19(7):949-56. PubMed ID: 20574666
[TBL] [Abstract][Full Text] [Related]
32. Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines.
Dupuis LL; Nathan PC
Paediatr Drugs; 2010; 12(1):51-61. PubMed ID: 20034341
[TBL] [Abstract][Full Text] [Related]
33. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
Perez EA
Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
[TBL] [Abstract][Full Text] [Related]
34. Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region.
Ide T; Nishino Y; Takiguchi T; Kanda S; Otsuki K; Hayashi R; Yasumoto K; Hirono Y; Makino T; Yano S; Koizumi T
BMC Pulm Med; 2023 Jun; 23(1):228. PubMed ID: 37365528
[TBL] [Abstract][Full Text] [Related]
35. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
Kris MG; Hesketh PJ; Herrstedt J; Rittenberg C; Einhorn LH; Grunberg S; Koeller J; Olver I; Borjeson S; Ballatori E
Support Care Cancer; 2005 Feb; 13(2):85-96. PubMed ID: 15565277
[TBL] [Abstract][Full Text] [Related]
36. Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.
Kris MG; Urba SG; Schwartzberg LS
Clin Adv Hematol Oncol; 2011 Jan; 9(1):suppl 1-15. PubMed ID: 21370520
[TBL] [Abstract][Full Text] [Related]
37. Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B).
Ozeki R; Iihara H; Shimokawa M; Hashimoto H; Abe M; Mukohara T; Bando H; Hayashi T; Kawazoe H; Komoda M; Yanai Takahashi T; Saito M
BMJ Open; 2022 Mar; 12(3):e058755. PubMed ID: 35236735
[TBL] [Abstract][Full Text] [Related]
38. Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.
Navari RM
Paediatr Drugs; 2017 Jun; 19(3):213-222. PubMed ID: 28447301
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.
Yokoe T; Hayashida T; Nagayama A; Nakashoji A; Maeda H; Seki T; Takahashi M; Takano T; Abe T; Kitagawa Y
Oncologist; 2019 Jun; 24(6):e347-e357. PubMed ID: 30333194
[TBL] [Abstract][Full Text] [Related]
40. Prevention of gastrointestinal side-effects in paediatric oncology: what are the guidelines?
Cheng KKF
Curr Opin Support Palliat Care; 2017 Jun; 11(2):120-124. PubMed ID: 28333866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
